BetterLife Pharma Inc. (BETRF) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1275 WEST 6TH AVENUE VANCOUVER, BC V6H 1A6 |
| State of Incorp. | BC |
| Fiscal Year End | January 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 4/30/2019 MRQ | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | 1/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 75 | 65 | 112 | 72 | 1 | 1 | |||
| Cash and cash equivalents | 75 | 65 | 112 | 72 | 1 | 1 | |||
| Receivables | 0 | ||||||||
| Prepaid expense | 123 | 85 | 17 | 32 | |||||
| Other undisclosed current assets | 44 | 5 | |||||||
| Total current assets: | 242 | 149 | 130 | 103 | 1 | 6 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 4 | 0 | 1 | ||||||
| Intangible assets, net (including goodwill) | 8,350 | 235 | ✕ | ||||||
| Intangible assets, net (excluding goodwill) | 8,350 | 235 | |||||||
| Deposits noncurrent assets | 3 | 3 | |||||||
| Total noncurrent assets: | 8,354 | 235 | 3 | 3 | 0 | 1 | |||
| TOTAL ASSETS: | 8,596 | 384 | 133 | 106 | 2 | 7 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Debt | 3,498 | 200 | 275 | 287 | |||||
| Derivative instruments and hedges, liabilities | 313 | 19 | 200 | ||||||
| Due to related parties | 330 | 10 | 23 | 38 | |||||
| Other undisclosed current liabilities | 997 | 52 | 242 | ||||||
| Total current liabilities: | 3,828 | 210 | 1,607 | 38 | 71 | 729 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 29 | ||||||||
| Total noncurrent liabilities: | 29 | ||||||||
| Other undisclosed liabilities | 1,258 | 219 | 397 | ||||||
| Total liabilities: | 5,086 | 429 | 1,607 | 435 | 71 | 758 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 3,510 | (45) | (1,474) | (329) | (69) | (748) | |||
| Common stock | 21,340 | 8,264 | 7,328 | 7,054 | 3,834 | 1,151 | |||
| Additional paid in capital | 16,999 | 11,816 | 11,211 | 4,575 | 268 | 788 | |||
| Accumulated other comprehensive income | 123 | 594 | 585 | 617 | |||||
| Retained earnings (accumulated deficit) | (34,963) | (20,719) | (20,598) | (12,591) | (4,171) | 751 | |||
| Other undisclosed equity, attributable to parent | 10 | 16 | (3,438) | ||||||
| Other undisclosed equity | (3) | ||||||||
| Total equity: | 3,510 | (45) | (1,474) | (329) | (69) | (751) | |||
| TOTAL LIABILITIES AND EQUITY: | 8,596 | 384 | 133 | 106 | 2 | 7 | |||
Income Statement (P&L) ($ in thousands)
| 4/30/2019 TTM | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | 1/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Financial Services Revenue) | 247 | |||||||
| Cost of revenue (Cost of Goods and Services Sold) | (9) | (303) | (4,119) | (2,268) | (3) | |||
| Gross profit: | (9) | (57) | (4,119) | (2,268) | (3) | |||
| Operating expenses | (6,844) | (1,049) | (6,024) | (8,593) | (131) | (77) | ||
| Other undisclosed operating income | 9 | 57 | 4,119 | 2,268 | ||||
| Operating loss: | (6,844) | (1,049) | (6,024) | (8,593) | (134) | (77) | ||
| Nonoperating income (expense) (Gain (Loss), Foreign Currency Transaction, before Tax) | (59) | 31 | ||||||
| Interest and debt expense | (391) | (27) | (12) | (72) | 35 | |||
| Loss from continuing operations before income taxes: | (7,235) | (1,077) | (6,035) | (8,593) | (265) | (11) | ||
| Income tax expense (benefit) | (1,383) | (1,208) | 52 | |||||
| Loss from continuing operations: | (7,235) | (1,077) | (7,419) | (9,801) | (213) | (11) | ||
| Loss before gain (loss) on sale of properties: | (7,235) | (1,077) | (7,419) | (9,801) | (213) | (11) | ||
| Other undisclosed net income (loss) | 980 | 1,614 | (743) | |||||
| Net loss: | (7,235) | (1,077) | (6,439) | (8,187) | (213) | (754) | ||
| Other undisclosed net income (loss) attributable to parent | (1,911) | 955 | 160 | (392) | (1,044) | (0) | ||
| Net loss available to common stockholders, diluted: | (9,146) | (121) | (6,278) | (8,578) | (1,257) | (754) | ||
Comprehensive Income ($ in thousands)
| 4/30/2019 TTM | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | 1/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7,235) | (1,077) | (6,439) | (8,187) | (213) | (754) | ||
| Comprehensive loss: | (7,235) | (1,077) | (6,439) | (8,187) | (213) | (754) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1,788) | 964 | (56) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (9,023) | (112) | (6,439) | (8,242) | (213) | (754) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.